Chirag N Patel
Overview
Explore the profile of Chirag N Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Batra B, Srinivasan S, Gopalakrishnan S, Patel C, Kumar V, Sourirajan A, et al.
J Biomol Struct Dyn
. 2023 Jan;
41(22):12880-12907.
PMID: 36690609
SARS-CoV-2 has mutated many times among different populations. We analyzed wild-type spike protein and 18 different variants of SARS-CoV-2 spike protein known until the beginning of 2022 (alpha, beta, B.1.429,...
12.
Sharma N, Gupta N, Orfali R, Kumar V, Patel C, Peng J, et al.
Molecules
. 2022 Nov;
27(22).
PMID: 36431765
Essential oils (EOs) have gained immense popularity due to considerable interest in the health, food, and pharmaceutical industries. The present study aimed to evaluate the antimicrobial and antioxidant activity and...
13.
Patel C, Jani S, Kumar S, Modi K, Kumar Y
Comput Biol Med
. 2022 Nov;
151(Pt A):106318.
PMID: 36423529
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is significantly impacting human lives, overburdening the healthcare system and weakening global economies. Plant-derived natural...
14.
Kumar S, Dixit N, Patel C, Rawal R, Pandya H
J Comput Chem
. 2022 Mar;
43(12):847-863.
PMID: 35301752
Structure-based pharmacophore models are often developed by selecting a single protein-ligand complex with good resolution and better binding affinity data which prevents the analysis of other structures having a similar...
15.
Rolta R, Salaria D, Sharma B, Awofisayo O, Fadare O, Sharma S, et al.
Curr Pharmacol Rep
. 2022 Mar;
8(2):149-170.
PMID: 35281252
Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s40495-021-00276-3.
16.
Patel C, Goswami D, Jaiswal D, Jani S, Parmar R, Rawal R, et al.
J Biomol Struct Dyn
. 2022 Jan;
41(6):2382-2397.
PMID: 35098887
Coronaviruses (CoVs) belong to a group of RNA viruses that cause diseases in vertebrates including. Newer and deadlier than SARS CoV-2 are sought to appear in future for which the...
17.
Mall S, Srivastava R, Sharma N, Patel C, Rolta R, Sourirajan A, et al.
Nat Prod Res
. 2021 Nov;
36(17):4532-4535.
PMID: 34825625
Hypertension has been a significant cause of death due to elevated blood pressure worldwide. The results of molecular docking showed out of selected 40 compounds, chasmanthin (-11.05 kcal/mol), and palmarin...
18.
Salaria D, Rolta R, Sharma N, Patel C, Ghosh A, Dev K, et al.
J Biomol Struct Dyn
. 2021 Nov;
40(24):14131-14145.
PMID: 34787050
(DC.) Stapf is an aromatic perennial herb of Gramineae (Poaceae) family and is known for its application in food and healthcare industry. The present study aimed to evaluate anti-inflammatory and...
19.
Patel C, Jani S, Jaiswal D, Kumar S, Mangukia N, Parmar R, et al.
Sci Rep
. 2021 Oct;
11(1):20295.
PMID: 34645849
Novel SARS-CoV-2, an etiological factor of Coronavirus disease 2019 (COVID-19), poses a great challenge to the public health care system. Among other druggable targets of SARS-Cov-2, the main protease (M)...
20.
Verma S, Patel C, Chandra M
J Comput Chem
. 2021 Jul;
42(26):1861-1872.
PMID: 34287986
Since December 2019, coronavirus disease (COVID-19) has claimed the lives of millions of people across the globe. To date, no medicine is available for the responsible virus SARS-CoV-2. 3CLpro, that...